AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Analysis shows Faslodex effective in treating metastatic breast cancer.
2004 JAN 1 - (NewsRx.com & NewsRx.net) -- Results from two pivotal phase III trials looking at overall survival demonstrate that Faslodex (fulvestrant) Injection is an effective alternative to Arimidex (anastrozole) Tablets in the treatment of postmenopausal women with advanced breast cancer who have progressed following tamoxifen.
The trials compared the efficacy and tolerability of Faslodex versus Arimidex in this patient population. This is the first time since the approval of Faslodex that mature survival data have been reported. This research provides physicians important new information to help women understand their choices if their disease progresses.
"As breast cancer research evolves, women are being offered more options for their breast cancer treatment," said John E. Pippen, MD, FACP, Baylor-Sammons Cancer Center, Dallas, Texas, and a lead trial investigator who presented the data. "These data reinforce that women with advanced breast cancer have choices when other hormonal therapies fail."
The U.S. Food and Drug Administration (FDA) approved Faslodex in 2002 for the treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy, such as tamoxifen.
Faslodex is the only approved hormonal therapy for advanced breast cancer administered as a once-monthly intramuscular injection.
The two multicenter, randomized, controlled phase III trials compared the efficacy and tolerability of Faslodex (250 mg monthly intramuscular injection) with Arimidex (1 mg daily oral) in a total of 851 postmenopausal women with advanced breast cancer who had progressed on prior endocrine treatment.
...
- FASLODEX(R) (Fulvestrant) Added to Nationally Recognized Breast Cancer...
- Press release article from: PR Newswire April 24, 2003 700+ words
...Guidelines in Oncology for Breast Cancer." FASLODEX is included in their...postmenopausal women with breast cancer, treatment with FASLODEX showed a decrease...estrogen receptors in breast cancer cells. FASLODEX is administered as...
- New Breakthrough Treatment For Breast Cancer, Faslodex Launched In UK Today.
- Press release article from: PR Newswire May 12, 2004 700+ words
...provides new choice for women with advanced breast cancer. A new breast cancer drug, Faslodex(TM) (fulvestrant), was launched today...quality of life for women with advanced breast cancer. Faslodex is a long-acting, once-monthly injection...
- New Clinical Trial of FASLODEX(R) (Fulvestrant) Seeks to Identify Additional...
- Press release article from: PR Newswire August 6, 2003 700+ words
...effectiveness of FASLODEX in patients with advanced breast cancer whose disease has...postmenopausal women with breast cancer, treatment with FASLODEX showed a decrease...estrogen receptors in breast cancer cells. FASLODEX is administered...
- New Data Reported on FASLODEX(R) (Fulvestrant) Injection in Postmenopausal...
- Press release article from: PR Newswire December 11, 2004 700+ words
...treatment with FASLODEX in 67 postmenopausal...women with advanced breast cancer who had previously...treatment with FASLODEX in 77 postmenopausal...women with advanced breast cancer, who had disease...as tamoxifen. FASLODEX is the only approved...therapy for advanced ...
- Survival Analysis Supports Use of FASLODEX as an Effective Option for...
- Press release article from: PR Newswire December 5, 2003 700+ words
...FDA) approved FASLODEX in 2002 for the...positive metastatic breast cancer in postmenopausal...as tamoxifen. FASLODEX is the only approved...therapy for advanced breast cancer administered as...positive metastatic breast cancer. The trial, called...Evaluation of ...
- FASLODEX AS EFFECTIVE AS ARIMIDEX IN ADVANCED BREAST CANCER.
- News wire article from: AsiaPulse News December 8, 2003 700+ words
...women with advanced breast cancer treated with the...receptor antagonist, 'Faslodex', have comparable...reminders of their breast cancer. The data confirm that 'Faslodex' is a valuable...positive metastatic breast cancer in post-menopausal...
- Clinical potential of Faslodex established in Phase III data.(breast cancer)
- Magazine article from: Women's Health Weekly October 31, 2002 700+ words
...resistant advanced breast cancer, confirming that Faslodex works in a...receptor, Faslodex targets and...receptors in breast cancer cells. In...Henderson, a noted breast cancer expert from...concludes that Faslodex is one of a...
- Analysis shows Faslodex effective in treating metastatic breast cancer.
- Newspaper article from: Pharma Business Week December 29, 2003 700+ words
...FDA) approved Faslodex in 2002 for the...positive metastatic breast cancer in postmenopausal...as tamoxifen. Faslodex is the only approved...therapy for advanced breast cancer administered as...positive metastatic breast cancer. The trial, called...Evaluation of ...
